Carlson Capital Arbitrage Profits From Celgene/Bristol-Myers Mega Deal – ValueWalk Premium

Carlson Capital Arbitrage Profits From Celgene/Bristol-Myers Mega Deal

Carlson Capital's Black Diamond Arbitrage Partners fund returned 1.62% net of fees for investors for the first quarter of 2019. According to a copy of the fund's first quarter investor update, a copy of which has been reviewed by ValueWalk, during the quarter merger arbitrage investments contributed 178 basis points to performance while special situations and other event-driven positions added 49 basis points.

Q1 hedge fund letters, conference, scoops etc

For more up-to-date hedge fund content, and exclusive access to value-focused hedge fund managers, check out ValueWalk’s exclusive value newsletter, Hidden Value Stocks.

Even though the total value of global mergers and acquisitions announced during the first quarter of 2019, was down year-on-year, the team at Carlson's Arbitrage Fund notes the "universe of mega-cap strategic deals continues to expand," and more importantly, activity is diversified across industries with no-one industry accounting for an overbearing percentage of M&A.


This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.

Saved Articles